|The GSK-3 family as therapeutic target for myocardial diseases|
H Lal, F Ahmad, J Woodgett, T Force
Circulation research 116 (1), 138-149, 2015
|Cardiac fibroblast glycogen synthase kinase-3β regulates ventricular remodeling and dysfunction in ischemic heart|
H Lal, F Ahmad, J Zhou, JE Yu, RJ Vagnozzi, Y Guo, D Yu, EJ Tsai, ...
Circulation 130 (5), 419-430, 2014
|GSK-3α is a central regulator of age-related pathologies in mice|
J Zhou, TA Freeman, F Ahmad, X Shang, E Mangano, E Gao, J Farber, ...
The Journal of Clinical Investigation 123 (4), 1821, 2013
|GSK-3α Limits Ischemic Injury, Cardiac Rupture, Post-Myocardial Infarction Remodeling and Death|
H Lal, J Zhou, F Ahmad, R Zaka, RJ Vagnozzi, M DeCaul, J Woodgett, ...
Circulation 125 (1), 65-75, 2012
|Loss of adult cardiac myocyte GSK-3 leads to mitotic catastrophe resulting in fatal dilated cardiomyopathy|
J Zhou, F Ahmad, S Parikh, NE Hoffman, S Rajan, VK Verma, J Song, ...
Circulation research 118 (8), 1208-1222, 2016
|Molecular defects in ITGA2B and ITGB3 genes in patients with Glanzmann thrombasthenia|
M Kannan, F Ahmad, BK Yadav, R Kumar, VP Choudhry, R Saxena
Journal of Thrombosis and Haemostasis 7 (11), 1878-1885, 2009
|Cardiomyocyte-Specific Deletion of Gsk3α Mitigates Post–Myocardial Infarction Remodeling, Contractile Dysfunction, and Heart Failure|
F Ahmad, H Lal, J Zhou, RJ Vagnozzi, JE Yu, X Shang, JR Woodgett, ...
Journal of the American College of Cardiology 64 (7), 696-706, 2014
|Relative contributions of stromal interaction molecule 1 and CalDAG‐GEFI to calcium‐dependent platelet activation and thrombosis|
F Ahmad, Y Boulaftali, TK Greene, TD Ouellette, M Poncz, S Feske, ...
Journal of Thrombosis and Haemostasis 9 (10), 2077-2086, 2011
|Inherited platelet function disorders versus other inherited bleeding disorders: An Indian overview|
F Ahmad, M Kannan, R Ranjan, J Bajaj, VP Choudhary, R Saxena
Thrombosis research 121 (6), 835-841, 2008
|Human genome-wide association and mouse knockout approaches identify platelet supervillin as an inhibitor of thrombus formation under shear stress|
LC Edelstein, EJ Luna, IB Gibson, M Bray, Y Jin, A Kondkar, S Nagalla, ...
Circulation 125 (22), 2762-2771, 2012
|Characterisation of mutations and molecular studies of type 2 von Willebrand disease|
F Ahmad, R Jan, M Kannan, T Obser, MI Hassan, F Oyen, U Budde, ...
Thrombosis and haemostasis 109 (1), 39-46, 2013
|Troponin I-Interacting Protein Kinase–A Novel Cardiac-Specific Kinase, Emerging as a Molecular Target for the Treatment of Cardiac Disease–|
H Lal, F Ahmad, S Parikh, T Force
Circulation Journal, CJ-14-0543, 2014
|Evidence for non-HFE linked hemochromatosis in Asian Indians|
I Panigrahi, F Ahmad, R Kapoor, PK Sharma, G Makharia, R Saxena
Indian journal of medical sciences 60 (12), 491-495, 2006
|Platelet activation markers in evaluation of thrombotic risk factors in various clinical settings|
M Kannan, F Ahmad, R Saxena
Blood reviews 37, 100583, 2019
|Functional characterization of antibodies against heparin–platelet factor 4 complex in heparin-induced thrombocytopenia patients in Asian-Indians: relevance to inflammatory markers|
M Kannan, S Ahmad, F Ahmad, S Kale, DA Hoppensteadt, J Fareed, ...
Blood coagulation & fibrinolysis 16 (7), 487-490, 2005
|Cardiomyocyte-specific deletion of GSK-3β leads to cardiac dysfunction in a diet induced obesity model|
M Gupte, S Tumuluru, JY Sui, AP Singh, P Umbarkar, SS Parikh, F Ahmad, ...
International journal of cardiology 259, 145-152, 2018
|Impact of 789Ala/Ala genotype on quantitative type of von Willebrand disease|
F Ahmad, M Kannan, A Biswas, R Saxena
Annals of hematology 88 (5), 479-483, 2009
|Phenotypic and molecular characterisation of type 3 von Willebrand disease in a cohort of Indian patients|
F Ahmad, U Budde, R Jan, F Oyen, M Kannan, R Saxena, ...
Thromb Haemost 109 (4), 652-60, 2013
|Carrier detection in Glanzmann thrombasthenia: comparison of flow cytometry and Western blot with respect to DNA mutation|
M Kannan, F Ahmad, BK Yadav, P Kumar, P Jain, R Kumar, R Saxena
American journal of clinical pathology 130 (1), 93-98, 2008
|Cardiomyocyte-GSK-3α promotes mPTP opening and heart failure in mice with chronic pressure overload|
F Ahmad, AP Singh, D Tomar, M Rahmani, Q Zhang, JR Woodgett, ...
Journal of molecular and cellular cardiology 130, 65-75, 2019